2026-06-07 Drugs SFDA Grants Orphan Drug Designation to “Gomekli” for the Treatment of Neurofibromatosis Type 1 (NF1)
2026-06-04 Drugs The SFDA Grants Breakthrough Designation to "ZENBEXUS" for the Treatment of Adult Patients with Multiple Myeloma
2026-05-24 The Authority, Drugs SFDA Grants Breakthrough Designation to Prevent and Reduce Bleeding Episodes in Patients with Hemophilia A
2026-05-15 Drugs SFDA Approves Registration of New Treatment for Advanced or Metastatic Breast Cancer with a Gene Mutation
2026-03-10 Drugs SFDA Grants Breakthrough Designation to "Bemlayo" for Adults with Obesity or Overweight
2026-03-02 Drugs SFDA Grants Orphan Drug Designation to "HYRNUO" for Advanced Non-Small Cell Lung Cancer
